Depuy Orthopaedics
Clinical trials sponsored by Depuy Orthopaedics, explained in plain language.
Orthopaedic device division of Johnson & Johnson, focusing on joint replacement and trauma products.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New knee implant system tested for Second-Time replacement patients
Disease control OngoingThis study is testing the ATTUNE Revision Knee System in 400 people who need a second knee replacement (revision surgery). The goal is to see how well the implant holds up over 5 years and how it affects patients' pain, function, and quality of life. Participants will be followed…
Phase: NA • Sponsor: DePuy Orthopaedics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New knee implant system tested for tough first replacements
Disease control OngoingThis study is testing the ATTUNE Revision Knee System in 400 people who need a first knee replacement but have complex bone or joint issues. The implant is normally used for revision surgeries, but here it's being used for primary cases. Researchers will track how well patients c…
Phase: NA • Sponsor: DePuy Orthopaedics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New cementless knee implant aims to improve mobility in osteoarthritis patients
Disease control OngoingThis study is testing a new type of knee replacement implant that does not use cement to hold it in place. The implant, called ATTUNE Cementless Rotating Platform, is designed for people with osteoarthritis. Researchers will follow 540 patients for two years to see if their abili…
Phase: NA • Sponsor: DePuy Orthopaedics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC